Annual Accounts Receivable
$955.00 K
-$153.00 K-13.81%
01 June 2022
Summary:
Pluristem Therapeutics annual accounts receivable is currently $955.00 thousand, with the most recent change of -$153.00 thousand (-13.81%) on 01 June 2022. During the last 3 years, it has fallen by -$153.00 thousand (-13.81%).PSTI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
01 September 2022
Summary:
Pluristem Therapeutics quarterly accounts receivable is not available.PSTI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -13.8% | - |
| 5 y5 years | -23.2% | - |
PSTI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -57.8% |
Pluristem Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | $955.00 K(-13.8%) | $955.00 K(-13.8%) |
| June 2021 | $1.11 M(-11.2%) | $1.11 M(-11.2%) |
| June 2020 | $1.25 M(+0.4%) | $1.25 M(+0.4%) |
| June 2019 | $1.24 M(+80.1%) | $1.24 M(+336.1%) |
| Mar 2019 | - | $285.00 K(+247.6%) |
| Dec 2018 | - | $82.00 K(+121.6%) |
| Sept 2018 | - | $37.00 K(-94.6%) |
| June 2018 | $690.00 K(-33.4%) | $690.00 K(+15.8%) |
| Mar 2018 | - | $596.00 K(+246.5%) |
| Dec 2017 | - | $172.00 K(+588.0%) |
| Sept 2017 | - | $25.00 K(-97.6%) |
| June 2017 | $1.04 M(-54.0%) | $1.04 M(+225.8%) |
| Mar 2017 | - | $318.00 K(+10.8%) |
| Dec 2016 | - | $287.00 K(-37.5%) |
| Sept 2016 | - | $459.00 K(-79.6%) |
| June 2016 | $2.25 M(+29.7%) | $2.25 M(+1150.6%) |
| Mar 2016 | - | $180.00 K(+20.0%) |
| Dec 2015 | - | $150.00 K(-64.2%) |
| Sept 2015 | - | $419.00 K(-75.9%) |
| June 2015 | $1.74 M(-23.3%) | $1.74 M(+750.5%) |
| Mar 2015 | - | $204.00 K(+29.1%) |
| Dec 2014 | - | $158.00 K(-65.0%) |
| Sept 2014 | - | $451.00 K(-80.1%) |
| June 2014 | $2.26 M(+728.9%) | $2.26 M(+728.9%) |
| June 2013 | $273.00 K(+77.3%) | $273.00 K(-83.6%) |
| Sept 2012 | - | $1.67 M(-4.1%) |
| Mar 2012 | - | $1.74 M(-17.6%) |
| Dec 2011 | - | $2.11 M(+838.2%) |
| Sept 2011 | - | $225.00 K(+46.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | $154.00 K(-85.6%) | $154.00 K(-71.4%) |
| Mar 2011 | - | $538.00 K(-26.9%) |
| Dec 2010 | - | $736.00 K(+89.2%) |
| Sept 2010 | - | $389.00 K(-63.6%) |
| June 2010 | $1.07 M(+115.3%) | $1.07 M(+218.8%) |
| Mar 2010 | - | $335.00 K(+228.4%) |
| Dec 2009 | - | $102.00 K(-68.8%) |
| Sept 2009 | - | $327.00 K(-34.1%) |
| June 2009 | $496.00 K(+99.2%) | $496.00 K(+60.5%) |
| Mar 2009 | - | $309.00 K(-39.8%) |
| Dec 2008 | - | $513.00 K(+338.5%) |
| Sept 2008 | - | $117.00 K(-53.0%) |
| June 2008 | $249.00 K(-57.2%) | $249.00 K(-21.7%) |
| Mar 2008 | - | $318.00 K(-65.4%) |
| Dec 2007 | - | $920.00 K(-20.8%) |
| Sept 2007 | - | $1.16 M(+99.5%) |
| June 2007 | $582.40 K(+476.1%) | $582.40 K(+100.2%) |
| Mar 2007 | - | $290.90 K(+253.5%) |
| Dec 2006 | - | $82.30 K(+53.0%) |
| Sept 2006 | - | $53.80 K(-46.8%) |
| June 2006 | $101.10 K(-31.6%) | $101.10 K(+4.4%) |
| Mar 2006 | - | $96.80 K(+77.3%) |
| Dec 2005 | - | $54.60 K(-63.1%) |
| June 2005 | $147.80 K(+866.0%) | $147.80 K(+168.2%) |
| Mar 2005 | - | $55.10 K(+260.1%) |
| June 2004 | $15.30 K(+48.5%) | $15.30 K(-68.1%) |
| Mar 2004 | - | $48.00 K(+67.8%) |
| Dec 2003 | - | $28.60 K(+148.7%) |
| Sept 2003 | - | $11.50 K(+11.7%) |
| June 2003 | $10.30 K | $10.30 K |
FAQ
- What is Pluristem Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Pluristem Therapeutics?
- What is the all time high quarterly accounts receivable for Pluristem Therapeutics?
What is Pluristem Therapeutics annual accounts receivable?
The current annual accounts receivable of PSTI is $955.00 K
What is the all time high annual accounts receivable for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual accounts receivable is $2.26 M
What is the all time high quarterly accounts receivable for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly accounts receivable is $2.26 M